AXSOME THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
AXSOME THERAPEUTICS, INC. (AXSM) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 390.39 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-23.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-02-23
- AXSOME THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 28.46K shares, a 71.08% decline year-over-year.
- AXSOME THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 22.53K shares, a 69.85% decline year-over-year.
- AXSOME THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-06-30 was 64.82K shares, a 57.05% decline year-over-year.
- AXSOME THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-03-31 was 274.60K shares, a 69.36% decline year-over-year.
- AXSOME THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 390.39K shares, a 68.01% decline from fiscal 2024.
- AXSOME THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 1.22M shares, a 51.76% decline from fiscal 2023.
- AXSOME THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 2.53M shares, a 13.81% increase from fiscal 2022.
- AXSOME THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 2.22M shares, a 9.12% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2025-12-31 | 28.46K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | 50.98K shares derived: sum of 2 quarters · filed 2026-02-23 | 115.80K shares derived: sum of 3 quarters · filed 2026-02-23 | 390.39K shares 10-K · filed 2026-02-23 |
| 2025-09-30 | 22.53K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | 87.34K shares derived: sum of 2 quarters · filed 2025-11-03 | 361.94K shares 10-Q · filed 2025-11-03 | 460.34K shares derived: sum of 4 quarters · filed 2025-11-03 |
| 2025-06-30 | 64.82K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | 339.41K shares 10-Q · filed 2025-08-04 | 437.81K shares derived: sum of 3 quarters · filed 2025-08-04 | 512.52K shares derived: sum of 4 quarters · filed 2025-08-04 |
| 2025-03-31 | 274.60K shares 10-Q · filed 2025-05-05 | 372.99K shares derived: sum of 2 quarters · filed 2025-05-05 | 447.71K shares derived: sum of 3 quarters · filed 2025-05-05 | 598.61K shares derived: sum of 4 quarters · filed 2025-05-05 |
| 2024-12-31 | 98.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | 173.11K shares derived: sum of 2 quarters · filed 2025-02-18 | 324.01K shares derived: sum of 3 quarters · filed 2025-02-18 | 1.22M shares 10-K · filed 2025-02-18 |
| 2024-09-30 | 74.72K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 225.62K shares derived: sum of 2 quarters · filed 2024-11-12 | 1.12M shares 10-Q · filed 2024-11-12 | 1.49M shares derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | 150.90K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | 1.05M shares 10-Q · filed 2024-08-05 | 1.41M shares derived: sum of 3 quarters · filed 2024-08-05 | 1.84M shares derived: sum of 4 quarters · filed 2024-08-05 |
| 2024-03-31 | 896.28K shares 10-Q · filed 2024-05-06 | 1.26M shares derived: sum of 2 quarters · filed 2024-05-06 | 1.69M shares derived: sum of 3 quarters · filed 2024-05-06 | 1.89M shares derived: sum of 4 quarters · filed 2024-05-06 |
| 2023-12-31 | 364.36K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | 790.86K shares derived: sum of 2 quarters · filed 2024-02-23 | 992.81K shares derived: sum of 3 quarters · filed 2024-02-23 | 2.53M shares 10-K · filed 2024-02-23 |
| 2023-09-30 | 426.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | 628.45K shares derived: sum of 2 quarters · filed 2023-11-06 | 2.17M shares 10-Q · filed 2023-11-06 | 2.35M shares derived: sum of 4 quarters · filed 2023-11-06 |
| 2023-06-30 | 201.95K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | 1.74M shares 10-Q · filed 2023-08-07 | 1.92M shares derived: sum of 3 quarters · filed 2023-08-07 | 2.37M shares derived: sum of 4 quarters · filed 2023-08-07 |
| 2023-03-31 | 1.54M shares 10-Q · filed 2023-05-09 | 1.72M shares derived: sum of 2 quarters · filed 2023-05-09 | 2.17M shares derived: sum of 3 quarters · filed 2023-05-09 | 2.54M shares derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | 182.89K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | 632.44K shares derived: sum of 2 quarters · filed 2023-02-28 | 999.85K shares derived: sum of 3 quarters · filed 2023-02-28 | 2.22M shares 10-K · filed 2023-02-28 |
| 2022-09-30 | 449.55K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | 816.96K shares derived: sum of 2 quarters · filed 2022-11-07 | 2.04M shares 10-Q · filed 2022-11-07 | 2.80M shares derived: sum of 4 quarters · filed 2022-11-07 |
| 2022-06-30 | 367.41K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | 1.59M shares 10-Q · filed 2022-08-09 | 2.35M shares derived: sum of 3 quarters · filed 2022-08-09 | 2.67M shares derived: sum of 4 quarters · filed 2022-08-09 |
| 2022-03-31 | 1.22M shares 10-Q · filed 2022-05-02 | 1.98M shares derived: sum of 2 quarters · filed 2022-05-02 | 2.30M shares derived: sum of 3 quarters · filed 2022-05-02 | 2.48M shares derived: sum of 4 quarters · filed 2022-05-02 |
| 2021-12-31 | 757.91K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 1.08M shares derived: sum of 2 quarters · filed 2022-03-01 | 1.26M shares derived: sum of 3 quarters · filed 2022-03-01 | 2.04M shares 10-K · filed 2022-03-01 |
| 2021-09-30 | 323.94K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | 498.71K shares derived: sum of 2 quarters · filed 2021-11-08 | 1.28M shares 10-Q · filed 2021-11-08 | 1.29M shares derived: sum of 4 quarters · filed 2021-11-08 |
| 2021-06-30 | 174.77K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | 955.21K shares 10-Q · filed 2021-08-09 | 961.85K shares derived: sum of 3 quarters · filed 2021-08-09 | 974.22K shares derived: sum of 4 quarters · filed 2021-08-09 |
| 2021-03-31 | 780.44K shares 10-Q · filed 2021-05-10 | 787.07K shares derived: sum of 2 quarters · filed 2021-05-10 | 799.45K shares derived: sum of 3 quarters · filed 2021-05-10 | 862.77K shares derived: sum of 4 quarters · filed 2021-05-10 |
| 2020-12-31 | 6.63K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | 19.01K shares derived: sum of 2 quarters · filed 2021-03-01 | 82.33K shares derived: sum of 3 quarters · filed 2021-03-01 | 649.14K shares 10-K · filed 2021-03-01 |
| 2020-09-30 | 12.37K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | 75.69K shares derived: sum of 2 quarters · filed 2020-11-05 | 642.51K shares 10-Q · filed 2020-11-05 | 929.63K shares derived: sum of 4 quarters · filed 2020-11-05 |
| 2020-06-30 | 63.32K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | 630.13K shares 10-Q · filed 2020-08-10 | 917.26K shares derived: sum of 3 quarters · filed 2020-08-10 | 1.14M shares derived: sum of 4 quarters · filed 2020-08-10 |
| 2020-03-31 | 566.82K shares 10-Q · filed 2020-05-11 | 853.94K shares derived: sum of 2 quarters · filed 2020-05-11 | 1.08M shares derived: sum of 3 quarters · filed 2020-05-11 | 1.16M shares derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-12-31 | 287.12K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | 514.43K shares derived: sum of 2 quarters · filed 2020-03-12 | 593.49K shares derived: sum of 3 quarters · filed 2020-03-12 | 1.48M shares 10-K · filed 2020-03-12 |
| 2019-09-30 | 227.31K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | 306.37K shares derived: sum of 2 quarters · filed 2019-11-07 | 1.20M shares 10-Q · filed 2019-11-07 | 1.24M shares derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-06-30 | 79.06K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | 969.92K shares 10-Q · filed 2019-08-08 | 1.01M shares derived: sum of 3 quarters · filed 2019-08-08 | 1.03M shares derived: sum of 4 quarters · filed 2019-08-08 |
| 2019-03-31 | 890.87K shares 10-Q · filed 2019-05-09 | 931.03K shares derived: sum of 2 quarters · filed 2019-05-09 | 949.68K shares derived: sum of 3 quarters · filed 2019-05-09 | 1.26M shares derived: sum of 4 quarters · filed 2019-05-09 |
| 2018-12-31 | 40.16K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | 58.82K shares derived: sum of 2 quarters · filed 2019-03-15 | 364.46K shares derived: sum of 3 quarters · filed 2019-03-15 | 816.72K shares 10-K · filed 2019-03-15 |
| 2018-09-30 | 18.65K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | 324.30K shares derived: sum of 2 quarters · filed 2018-11-09 | 776.56K shares 10-Q · filed 2018-11-09 | 855.50K shares derived: sum of 4 quarters · filed 2018-11-09 |
| 2018-06-30 | 305.65K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | 757.90K shares 10-Q · filed 2018-08-08 | 836.84K shares derived: sum of 3 quarters · filed 2018-08-08 | 1.09M shares derived: sum of 4 quarters · filed 2018-08-08 |
| 2018-03-31 | 452.26K shares 10-Q · filed 2018-05-08 | 531.20K shares derived: sum of 2 quarters · filed 2018-05-08 | 784.70K shares derived: sum of 3 quarters · filed 2018-05-08 | 842.25K shares derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-12-31 | 78.94K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | 332.44K shares derived: sum of 2 quarters · filed 2018-03-07 | 390.00K shares derived: sum of 3 quarters · filed 2018-03-07 | 847.51K shares 10-K · filed 2018-03-07 |
| 2017-09-30 | 253.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | 311.06K shares derived: sum of 2 quarters · filed 2017-11-08 | 768.57K shares 10-Q · filed 2017-11-08 | 776.40K shares derived: sum of 4 quarters · filed 2017-11-08 |
| 2017-06-30 | 57.56K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | 515.07K shares 10-Q · filed 2017-08-09 | 522.90K shares derived: sum of 3 quarters · filed 2017-08-09 | 547.19K shares derived: sum of 4 quarters · filed 2017-08-09 |
| 2017-03-31 | 457.51K shares 10-Q · filed 2017-05-09 | 465.35K shares derived: sum of 2 quarters · filed 2017-05-09 | 489.63K shares derived: sum of 3 quarters · filed 2017-05-09 | 1.25M shares derived: sum of 4 quarters · filed 2017-05-09 |
| 2016-12-31 | 7.83K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-07 | 32.11K shares derived: sum of 2 quarters · filed 2017-03-07 | 794.49K shares derived: sum of 3 quarters · filed 2017-03-07 | 794.49K shares 10-K · filed 2017-03-07 |
| 2016-09-30 | 24.28K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | 786.65K shares derived: sum of 2 quarters · filed 2016-11-14 | 786.65K shares 10-Q · filed 2016-11-14 | |
| 2016-06-30 | 762.37K shares derived: 10-Q 6 month − 10-Q/A 3 month · filed 2016-08-09 | 762.37K shares 10-Q · filed 2016-08-09 | ||
| 2016-03-31 | 0.00 shares 10-Q/A · filed 2016-08-09 | |||
| 2015-12-31 | 438.29K shares 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |